Your browser doesn't support javascript.
loading
Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
Lee, Jae-Hyun; Lee, Chang-Min; Lee, Joyce H; Kim, Mun-Ock; Park, Jin Wook; Kamle, Suchitra; Akosman, Bedia; Herzog, Erica L; Peng, Xue Yan; Elias, Jack A; Lee, Chun Geun.
Afiliação
  • Lee JH; Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee CM; Department Molecular Microbiology and Immunology and.
  • Lee JH; Department Molecular Microbiology and Immunology and.
  • Kim MO; Natural Medicine Research Center, KRIBB, Cheongju-si, Chungcheongbuk-do, South Korea; and.
  • Park JW; Department Molecular Microbiology and Immunology and.
  • Kamle S; Department Molecular Microbiology and Immunology and.
  • Akosman B; Department Molecular Microbiology and Immunology and.
  • Herzog EL; Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Peng XY; Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Elias JA; Department Molecular Microbiology and Immunology and.
  • Lee CG; Warren Alpert School of Medicine, Brown University, Providence, Rhode Island.
Am J Respir Cell Mol Biol ; 67(3): 309-319, 2022 09.
Article em En | MEDLINE | ID: mdl-35679109

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Quitinases / Antifibróticos / Aminoglicosídeos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Am J Respir Cell Mol Biol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Quitinases / Antifibróticos / Aminoglicosídeos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Am J Respir Cell Mol Biol Ano de publicação: 2022 Tipo de documento: Article